{"date":"2025-08-19","count":18,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6748-2025-08-19-1706-11xbh9h","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-19","time":"17:06:26","subject":"公告本公司「膠原蛋白顆粒於促進毛囊生成或血管生成之用途/USE OF COLLAGEN PARTICLES IN HAIR FOLLICLES FORMATION ORANGIOGENESIS」取得日本發明專利核准審定書","clause":"第44款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-08-19 17:06，「公告本公司「膠原蛋白顆粒於促進毛囊生成或血管生成之用途/USE OF COLLAGEN PARTICLES IN HAI」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-08-19-1648-1lmv9jb","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-08-19","time":"16:48:26","subject":"公告補正本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-08-19 16:48，「公告補正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-08-19-1627-8ujb8r","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-08-19","time":"16:27:59","subject":"公告本公司股票初次上櫃前現金增資收足股款暨現金增資基準日","clause":"第44款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-08-19 16:27，「公告本公司股票初次上櫃前現金增資收足股款暨現金增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-08-19-1625-1jhewlf","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-08-19","time":"16:25:57","subject":"公告本公司公司治理主管異動","clause":"第8款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-08-19 16:25，「公告本公司公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-08-19-1625-195u4es","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-08-19","time":"16:25:14","subject":"本公司修訂「中華民國境內第三次無擔保轉換公司債發行及轉換辦法」之債權人公告","clause":"第51款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-08-19 16:25，「本公司修訂「中華民國境內第三次無擔保轉換公司債發行及轉換辦法」之債權人公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-08-19-1623-1yg50va","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-08-19","time":"16:23:05","subject":"公告本公司董事會決議召開114年第一次股東臨時會相關事宜(增列召集事由)","clause":"第32款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-08-19 16:23，「公告本公司董事會決議召開114年第一次股東臨時會相關事宜(增列召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-08-19-1611-u2anbv","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-08-19","time":"16:11:36","subject":"公告修訂本公司中華民國境內第三次無擔保轉換公司債發行及轉換辦法","clause":"第11款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-08-19 16:11，「公告修訂本公司中華民國境內第三次無擔保轉換公司債發行及轉換辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-08-19-1611-1h3ceio","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-19","time":"16:11:23","subject":"公告本公司董事會決議買回庫藏股","clause":"第35款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-08-19 16:11，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-08-19-1610-98tuyd","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-08-19","time":"16:10:17","subject":"本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第11款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-08-19 16:10，「本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-08-19-1606-1wsnfiw","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-19","time":"16:06:08","subject":"代子公司太景生物科技(股)公司依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款公告","clause":"第23款","fact_date":"2025-08-20","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-08-19 16:06，「代子公司太景生物科技(股)公司依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-08-19-1601-wdgv9n","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-08-19","time":"16:01:31","subject":"代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第二款、第三款及第四款之規定公告","clause":"第22款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-08-19 16:01，「代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第二款、第三款及第四款之規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-08-19-1600-yixmr4","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-08-19","time":"16:00:26","subject":"公告本公司董事會通過取得望德斯國際股份有限公司30%股權案","clause":"第17款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-08-19 16:00，「公告本公司董事會通過取得望德斯國際股份有限公司30%股權案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-08-19-1559-qtr0qk","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-19","time":"15:59:41","subject":"本公司董事長訂定現金增資發行新股認股基準日等相關事宜","clause":"第9款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-08-19 15:59，「本公司董事長訂定現金增資發行新股認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-08-19-1558-xjpbwf","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-08-19","time":"15:58:27","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第三款及第四款之規定公告","clause":"第22款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-08-19 15:58，「本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第三款及第四款之規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-08-19-1555-ofgaj3","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-08-19","time":"15:55:34","subject":"代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款之規定公告","clause":"第23款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-08-19 15:55，「代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款之規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-08-19-1552-xyhazt","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-08-19","time":"15:52:54","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-08-19 15:52，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-08-19-1539-pbsb4a","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-19","time":"15:39:57","subject":"公告本公司董事會通過114年第二季合併財報","clause":"第31款","fact_date":"2025-08-19","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-08-19 15:39，「公告本公司董事會通過114年第二季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-08-19-1448-16sohr8","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-08-19","time":"14:48:27","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-08-25","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-08-19 14:48，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}